www.fdanews.com/articles/96474-ranbaxy-forays-into-authorised-generics-in-u-s
Ranbaxy Forays Into Authorised Generics in U.S.
July 30, 2007
Pharmaceutical major Ranbaxy Laboratories on Monday said it has commercialised its first authorised generic product, Isoptin SR — an antihypertensive agent — in the U.S. market.
The Economic Times